Association of red cell distribution width with chronic obstructive pulmonary disease severity
DOI:
https://doi.org/10.59736/IJP.24.03.1108Keywords:
COPD, GOLD Classification, Inflammation, Pulmonary FunctionAbstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease that has substantial morbidity and mortality worldwide. A widely used blood parameter, called Red Cell Distribution Width (RDW), has been proposed as a marker of inflammation and disease severity in COPD. Our objective is to find the correlation between RDW and COPD severity based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification.
Methods: This cross-sectional study was carried out in the Pulmonology Department, Khyber Teaching Hospital, Peshawar from 23-05-2025 to 03-04-2026. Non-probability consecutive sampling was used to recruit a total of 258 confirmed cases of COPD. Demographic and clinical information was taken. The severity of COPD was determined by the GOLD staging. RDW was determined by complete blood count (CBC) and classified as high (>14.5%) or normal (≤14.5%). The data were analyzed using SPSS-27 and the Chi-square test, One-way ANOVA and Pearson correlation coefficient with p<0.05 as significant value.
Results: The mean age of the participants was 62.9±10.3 years and 68.2% were male. 57.8% of patients were found to have an elevated RDW. A majority of patients had severe to very severe disease (GOLD III-IV) (49.6%) and the majority were in GOLD II (35.7%) and III (31.4%). There was a strong correlation between RDW and COPD severity (p<0.001), as it rose from 26.3% in GOLD I to 83.0% in GOLD IV. Mean RDW rose significantly across stages (13.4±0.8% to 16.2±1.7%). A negative correlation was found between RDW and FEV₁ (% predicted) (r=-0.58, p<0.001). Conclusion: An increased RDW was significantly related to the severity of COPD and lung function, which indicated its potential to be a simple, low-cost biomarker for disease evaluation.
References
Agustí A, Melén E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022;10(5):512-24.
Nucera F, Mumby S, Paudel KR, Dharwal V, Di Stefano A, Casolaro V, et al. Role of oxidative stress in the pathogenesis of COPD. Minerva Med. 2022 Feb 10.
World Health Organization. Health inequities and their causes . Geneva: World Health Organization; 2017. https://www.who.int/newsroom/facts-in-pictures/detail/health-inequities-and-their-causes
Tzanakis N, Koulouris N, Dimakou K, Gourgoulianis K, Kosmas E, Chasapidou G, et al. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulm Med. 2021;21(1):216.
Xu W, Huo J, Chen G, Yang K, Huang Z, Peng L, et al. Association between red blood cell distribution width to albumin ratio and prognosis of patients with sepsis: a retrospective cohort study. Front Nutr. 2022; 9:1019502.
Karampitsakos T, Dimakou K, Papaioannou O, Chrysikos S, Kaponi M, Bouros D, et al. The role of increased red cell distribution width as a negative prognostic marker in patients with COPD. Pulm Pharmacol Ther. 2020; 60:101877.
Marvisi M, Mancini C, Balzarini L, Ramponi S. Red cell distribution width: a new parameter for predicting the risk of exacerbation in COPD patients. Int J Clin Pract. 2021;75(9).
Kanwal A, Bashir A, Gohier A, Habib B. Association of red blood cell indices and erythrocyte sedimentation rate in chronic obstructive pulmonary disease (COPD) patients. Pak Armed Forces Med J. 2021;71(2):610.
Farman S, Saad M, Adnan U. Red cell distribution width as a prognostic marker in ICU-admitted chronic obstructive pulmonary disease patients: correlation with inflammatory profile and clinical outcomes. Pak J Chest Med. 2024;30(2):219-28.
Yu K, Gao A, He Y, Huang Z, Liu W. Red blood cell distribution width and mortality in chronic obstructive pulmonary disease patients with acute respiratory failure: a retrospective study. SciRep.2025;15(1):33391. doi:10.1038/s41598-025-18480-2.
Bari MA, Shamsi S, Hasan MJ, Ahmed S. Clinical profile of patients with chronic obstructive pulmonary disease
Community Based Med J. 2025;14(2):98-104.
Aykun G. Prognostic value of RDW and its contribution to scoring systems in patients with chronic obstructive pulmonary disease [preprint]. Research Square. 2025. doi:10.21203/rs.3.rs-6549201/v1.
Alparslan Bekir S, Tuncay E, Gungor S, Yalcinsoy M, Sogukpinar Ö, Gundogus B, et al. Can red blood cell distribution width (RDW) level predict the severity of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)? Int J Clin Pract.2021;75(11). doi:10.1111/ijcp.14730.
Arkew M, Gemechu K, Haile K, Asmerom H. Red blood cell distribution width as novel biomarker in cardiovascular diseases: a literature review. J Blood Med. 2022; 13:413-24. doi:10.2147/JBM.S367660.
Patidar P, Sharma A, Kurmi N, Takodara S, Syed A. Predictive biomarkers in chronicobstructivepulmonary.JLabPhysicians.2025;17(4):328. doi:10.25259/JLP_186_2024.
Saad E, Maamoun B, Nimer A. Increased red blood cell distribution predicts severity of chronic obstructive pulmonary disease exacerbation. J Pers Med.2023;13(5):843. doi:10.3390/jpm13050843.
Afzal M. Red cell distribution width (RDW) as a prognostic marker in systemic diseases: a mini review. Indian JHematol Blood Transfus. 2026;42(3):720-6.
doi:10.1007/s12288-025-02210-9.
Nâaroura A, Amar JB, Ouertani H, Jemia EB, Zaibi H, Aouina H. Could red cell distribution width predict COPD severity? Eur Respir J. 2023;62(Suppl 67). doi:10.1183/13993003.congress2023.PA627.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Abdur Rahman, Syed Akmal Shah, Saadia Ashraf, Muhammad Zubair Khan, Muhammad Jalal, Ejaz Ahmad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
